Introduction {#S1}
============

Atrial fibrillation (AF), one of the most prevalent heart rhythm disorders, is a potential cause of heart failure and ischemic stroke with high morbidity and mortality ([@B22]; [@B2]). The cause of AF is multifactorial which include age, male sex, diabetes, hypertension, valve disease, and systolic/diastolic dysfunction ([@B26]; [@B16]; [@B32]). Depends on how often atrial fibrillation occurs and how it responds to treatment, AF is roughly divided into two major subtypes-paroxysmal atrial fibrillation (PAF) and persistent atrial fibrillation (PeAF). In the treatment of AF, drugs were the first choice, non-drug therapies were used only when drug therapy failed or patients could not tolerate the medication. In contrast to the extensive knowledge of etiology, the underlying mechanism of AF remains elusive. Further study of the potential mechanisms of AF could provide novel strategies for the treatment and management to increase quality of life and reduce economic burden of social ([@B8]).

With the development of next generation sequencing (NGS) technologies, growing evidence have demonstrated that AF is a disease with a significant genetic contribution. Previous studies have filtered novel genetic variants and candidate genes including transcriptional factor genes (*PITX2, PRRX1, ZFHX3, NKX2.5*, *TBX5*), ion channel genes (*KCNN3*, *HCN4*, *CACNA1C*, *SCN5A*, *KCNQ1*, *KCNH2*), and caveolin genes (*CAV1* and *CAV2*) ([@B10]; [@B23]; [@B28]; [@B18]; [@B21]). However, these genes explain only a small fraction of the biology and genetic underpinnings of AF.

Epidemiological studies have demonstrated that genetic, environmental, behavioral, and clinical factors contribute to AF pathogenic mechanism ([@B37]). Emelia J. B performed genome-wide methylation using whole blood samples from 183 prevalent AF and 220 incident AF cases. They examined the association between DNA methylation and GWAS loci, suggesting DNA methylation might be a possible mechanism through which AF-specific genetic variations affect gene regulation ([@B15]). To date, only a few studies have investigated differential DNA methylation as a predictor biomarker at specific candidate loci that were previously associated with AF.

Therefore, we applied DNA methylation profiling study to identify the likely rare damaging variants and putative candidate genes from 10 patients with persistent atrial fibrillation (PeAF), 10 patients with paroxymal atrial fibrillation (PAF) and 10 healthy individuals. Interestingly, we identified top 10 genes (KIF15, ABCA3, FOXG1, VGF, PDE4D, EIF3C, CNTNAP5, SHOX2, VGF, TRIM59) as functional candidate genes and the expression level are significantly increased in PeAF and PAF patients than control. Given the importance of DNA methylation to gene expression, we investigated the gene expression of the same participants using RNA sequencing. We also defined top 10 genes (*EPN3*, *EMD*, *SMCO4*, *F2RL2*, *TMED1*, *PSMC3*, *PDZD11*, *NUDT6*, *TINAG*, *GALNT5*) in gene expression data and the expression pattern of these genes was significantly different between PeAF and PAF. These results have improved our understanding of the underlying mechanism and offer new insights into the potential pathway of AF, which could provide novel therapeutic option for this disease.

Materials and Methods {#S2}
=====================

Atrial Fibrillation Patients {#S2.SS1}
----------------------------

Ten patients with paroxymal atrial fibrillation (g1), 10 patients with persistent atrial fibrillation (continuous atrial fibrillation lasting more than 12 months) (g2) and 10 healthy individuals (g3) were enrolled in this study ([Table 1](#T1){ref-type="table"}). All patients were subjected to detailed medical evaluation, which included medical history, physical examination, electrocardiography (ECG), and echocardiography. Patients with chronic heart failure, coronary heart disease, cardiomyopathy, hyperthyroidism or chronic pulmonary heart disease were excluded.

###### 

Demographic characteristics of AF patients.

                                                Coronary             
  ---- ---- ------ ---- ----- ----- ----- ----- ---------- ---- ---- -----
  1    69   Male   76   169   No    Yes   No    Negative   70   40   --
  2    63   Male   64   170   No    No    No    Negative   59   46   --
  3    63   Male   70   170   No    No    No    Negative   66   39   --
  4    69   Male   67   173   No    Yes   No    Negative   67   46   --
  5    69   Male   75   165   No    No    No    Negative   70   36   --
  6    61   Male   76   176   No    Yes   Yes   Negative   60   42   --
  7    64   Male   52   168   Yes   No    No    Negative   64   40   --
  8    64   Male   71   181   No    Yes   Yes   Negative   63   39   --
  9    61   Male   87   167   Yes   Yes   No    Negative   62   37   --
  10   66   Male   82   173   No    Yes   No    Negative   63   42   --
  11   63   Male   86   176   No    Yes   No    Negative   57   46   2.5
  12   63   Male   80   178   No    No    No    Negative   68   55   3
  13   64   Male   70   170   No    No    No    Negative   67   41   4
  14   64   Male   84   164   No    Yes   No    Negative   55   48   2
  15   65   Male   73   169   No    Yes   No    Negative   69   55   3.5
  16   66   Male   66   168   No    Yes   No    Negative   64   45   4
  17   67   Male   80   175   No    Yes   Yes   Negative   59   47   2.5
  18   67   Male   73   165   Yes   Yes   No    Negative   59   47   3
  19   63   Male   61   164   No    No    No    Negative   73   49   2
  20   67   Male   90   178   No    Yes   No    Negative   70   58   2.5

LVEF, left ventricular ejection fraction; AF, atrial fibrillation; CTA, CT angiography.

The study was conducted in accordance with the Declaration of Helsinki, and the protocol used to collect human heart tissue was approved by the Ethics Committee of Shanghai East Hospital (DI: 0402017).

Written informed consents to participate in this study were provided by all the enrolled patients before operation of fibrillation ablation. The left atrial appendage tissues which were abandoned during isolated surgical ablation were collected. Normal left atrial appendages were collected from healthy male donors.

The Methylation Profiles {#S2.SS2}
------------------------

The DNA methylation status of 850K probes in the 30 samples was measured using Methylation EPICBead Chip. The raw data was quality controlled and preprocessed using R/Bioconductor package minfi^[1](#footnote1){ref-type="fn"}^ ([@B1]). The beta value ranged from 0 to 1 was calculated to represent how each position was methylated. 1 meant high methylation and 0 meant low methylation.

The RNA Sequencing Profiles {#S2.SS3}
---------------------------

The total RNAs were extracted using RNeasy Mini Kit (Cat\#74106, Qiagen) and the RNA integrity was checked using Agilent Bioanalyzer 2100 (Agilent technologies, Santa Clara, CA, United States). Qualified total RNA was further purified by RNAClean XP Kit (Cat A63987, Beckman Coulter Inc., Kraemer Boulevard, Brea, CA, United States) and RNase-Free DNase Set (Cat\#79254, QIAGEN, GmBH, Germany). Pair-end sequencing reads were generated using Illumina data collection software. First, the reads were mapped onto human reference genome GRCh38 using Hisat2 (version:2.0.4^[2](#footnote2){ref-type="fn"}^) ([@B12]). Then, Stringtie (version:1.3.0^[3](#footnote3){ref-type="fn"}^) ([@B24]) was used to calculate the FPKM (Fragments Per Kilobase of exon model per Million mapped reads).

Feature Selection Algorithm {#S2.SS4}
---------------------------

There were 866,091 methylation probes and 50,868 RNAs. The number of features were extremely large. It was difficult to select key features using traditional statistical methods. Therefore, we adopted the latest machine learning based feature selection method Boruta to get the key methylation probes and RNAs.

Boruta ([@B14]) is a feature selection method based on random forest. It can select sample group relevant features effectively. First, it will shuffle the features to create many permuted datasets. Then, it will evaluate the importance score of each feature in the original actual dataset and permuted datasets. Then, it will compare the actual importance score with permuted scores and find the features with significantly higher actual importance scores than permuted scores. After multiple iterations, it will select all the sample group relevant features. The python code from <https://github.com/scikit-learn-contrib/boruta_py> was used to apply the Boruta feature selection algorithm.

Classification Predictor {#S2.SS5}
------------------------

To evaluate how well the selected features can classify the samples, we built an SVM (Support Vector Machine) classifier using the methylation data and another RNA-Seq data based SVM classifier. The svm function in R package e10171^[4](#footnote4){ref-type="fn"}^ ([@B7]) was used to apply the SVM classification algorithm.

LOOCV (leave-one-out cross validation) was used to objectively evaluate the classification performance. Each time, one sample was treated as test sample while all the other samples were used to train the model. After 30 rounds, all samples had been tested once and the overall accuracy was calculated based on the confusion matrix. In confusion matrix, the actual sample groups were compared with predicted sample groups.

Results {#S3}
=======

The Key Methylation Features Identified With Boruta {#S3.SS1}
---------------------------------------------------

We ran Boruta feature selection algorithm on the methylation data and got 10 key methylation features. These 10 key methylation features were listed in [Table 2](#T2){ref-type="table"}. The probes were annotated to genome positions (Genome Build 37) and genes using the official annotation file from Illumina. Sometime, one position may be associated with multiple genes. Therefore, the 10 methylation probes can be mapped onto 15 gene symbols. We checked the GO annotation of these genes and found that cg16703882 (*SHOX2*) was associated with GO:0007507: heart development which was closely relevant to AF.

###### 

The 10 key methylation features identified by Boruta.

  ILMNID       Chromosome   Position    Strand   UCSC Ref gene name
  ------------ ------------ ----------- -------- -------------------------------------
  cg00702638   3            44803293    R        KIF15; KIAA1143
  cg02331561   16           2391081     F        ABCA17P; ABCA3
  cg02991338   14           29236017    R        FOXG1
  cg04084157   7            100809049   F        VGF
  cg05995159   5            59325256    R        PDE4D
  cg06357615   16           28403195    R        MIR6862-2; MIR6862-1; EIF3CL; EIF3C
  cg11344566   2            124782885   F        CNTNAP5
  cg16703882   3            157823479   R        SHOX2
  cg21186299   7            100808810   R        VGF
  cg26856080   3            160167746   R        TRIM59

We plotted the heatmap of these 10 key methylation features in [Figure 1](#F1){ref-type="fig"}. It can be seen that most of the 10 patients with paroxymal atrial fibrillation (g1), 10 patients with persistent atrial fibrillation (g2) and 10 healthy individuals (g3) were cluster into the right groups.

![The heatmap of the key methylation features. The 30 samples were from three groups: 10 patients with paroxymal atrial fibrillation (g1), 10 patients with persistent atrial fibrillation (g2), and 10 healthy individuals (g3). It can be seen that most samples were cluster into the right groups.](fbioe-08-00187-g001){#F1}

The Key Gene Expression Features Identified With Boruta {#S3.SS2}
-------------------------------------------------------

Similarly, we ran Boruta feature selection algorithm on the RNA-Seq gene expression data and got 10 key gene expression features. The 10 key gene expression features were given in [Table 3](#T3){ref-type="table"}. We also plotted their heatmap in [Figure 2](#F2){ref-type="fig"}. The clusters were also largely correct.

###### 

The 10 key gene expression features identified by Boruta.

  Gene ID           Name     Description                                               GRCh38 locus
  ----------------- -------- --------------------------------------------------------- -----------------------
  ENSG00000049283   EPN3     Epsin 3                                                   17:50532543-50543750
  ENSG00000102119   EMD      Emerin                                                    X:154379197-154381523
  ENSG00000166002   SMCO4    Single-pass membrane protein with coiled-coil domains 4   11:93478472-93543508
  ENSG00000164220   F2RL2    Coagulation factor II (thrombin) receptor-like 2          5:76615482-76623434
  ENSG00000099203   TMED1    Transmembrane p24 trafficking protein 1                   19:10832438-10836318
  ENSG00000165916   PSMC3    Proteasome 26S subunit, atpase 3                          11:47418769-47426473
  ENSG00000120509   PDZD11   PDZ domain containing 11                                  X:70286595-70290514
  ENSG00000170917   NUDT6    Nudix hydrolase 6                                         4:122888697-122922968
  ENSG00000137251   TINAG    Tubulointerstitial nephritis antigen                      6:54307859-54390152
  ENSG00000136542   GALNT5   Polypeptide N-acetylgalactosaminyltransferase 5           2:157257598-157314211

![The heatmap of the key gene expression features. The 30 samples were from three groups: 10 patients with paroxymal atrial fibrillation (g1), 10 patients with persistent atrial fibrillation (g2), and 10 healthy individuals (g3). It can be seen that most samples were cluster into the right groups.](fbioe-08-00187-g002){#F2}

The Classification Performance of Methylation and Gene Expression {#S3.SS3}
-----------------------------------------------------------------

From [Figures 1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}, we can see that both methylation and gene expression features can correctly cluster most samples. But we would like to evaluate their performance objectively and quantitatively. Therefore, we applied LOOCV to test the SVM classifiers of methylation and gene expression features. The confusion matrixes of methylation features and gene expression features were listed in [Tables 4](#T4){ref-type="table"}, [5](#T5){ref-type="table"}, respectively.

###### 

The confusion matrix of key methylation features.

              Predicted g1   Predicted g2   Predicted g3
  ----------- -------------- -------------- --------------
  Actual g1   8              2              0
  Actual g2   3              7              0
  Actual g3   0              0              10

###### 

The confusion matrix of key gene expression features.

              Predicted g1   Predicted g2   Predicted g3
  ----------- -------------- -------------- --------------
  Actual g1   9              0              1
  Actual g2   0              9              1
  Actual g3   1              0              9

From [Table 3](#T3){ref-type="table"}, we can see that the AF patients (g1 + g2) and healthy individuals (g3) were perfectly classified using the methylation features, but the methylation data did not have great performance on classifying the subtype of AF (g1 and g2). From [Table 4](#T4){ref-type="table"}, we can see that the two subtype of AF, paroxysmal atrial fibrillation (g1) and persistent atrial fibrillation (g2), had very different gene expression pattern. In other words, the methylation data and gene expression data complement each other. The methylation data can be used to predict the AF and the gene expression data can be used to classify the subtypes of AF.

We checked the wrongly predicted samples in [Tables 3](#T3){ref-type="table"}, [4](#T4){ref-type="table"}. They were different. Within the 30 samples, 22 samples had the same predicted labels by expression and methylation. All these 22 samples were correctly predicted. For the 8 inconsistent samples between expression and methylation predictions, at least one of the two predictions (the expression-based prediction and the methylation-based prediction) was correct. In other words, all the samples can be corrected classified based on either expression or methylation. The expression-based prediction and the methylation-based prediction were complementary.

The Methylation-Expression Regulation Network {#S3.SS4}
---------------------------------------------

We mapped the genes of methylation features and gene expression features to the STRING network (Version 11.0^[5](#footnote5){ref-type="fn"}^) ([@B29]) and visualized the network using R package igraph ([@B9])^[6](#footnote6){ref-type="fn"}^ to identify the potential relationship between two candidate genes sets. The methylation-expression regulation network was shown in [Figure 3](#F3){ref-type="fig"}. In the network, the methylation and expression genes were marked in red and green. The methylation genes located in three clusters: *EIF3CL-EIF3C*, *KIF15-TRIM59*, and *SHOX2-FOXG1-CNTNAP5*. The three expression genes (*PSMC3*, *TINAG*, and *NUDT6*) were connected with methylation gene *KIF15*. Even *EPN3* can be indirectly connected to *KIF15*. That made *KIF15* at the center of the network. These results suggested that *KIF5* may play important roles in the pathogenesis of AF.

![The methylation-expression regulation network. The red and green nodes were methylation and expression genes, respectively. The methylation genes located in three clusters: EIF3CL-EIF3C, KIF15-TRIM59, and SHOX2-FOXG1-CNTNAP5. KIF15 can directly or indirectly regulate the expression genes and may play important roles.](fbioe-08-00187-g003){#F3}

Discussion {#S4}
==========

DNA methylation, a pre-transcriptional modification characterized by the addition of methyl groups to specific nucleotides, regulates the stability of gene expression states and maintains genome integrity by collaborating with proteins that modify nucleosomes ([@B17]; [@B30]; [@B27]). Previous studies considered that changes in DNA methylation states contribute to the regulation of biological processes underlying AF, such as fibrosis, atrial dilatation, atrial fibroblast proliferation and differentiation from fibroblasts into myofibroblasts ([@B35]). To further enhance the biological understanding of the atrial fibrillation, our study focused on DNA methylation, particularly with respect to how it relates to mRNA expression. Among our two gene sets of top 10 genes, we found PDED4, SHOX2, and EMD were the most important genes for AF which have been reported associated with AF in previous reference.

Atrial fibrillation is reported to be associated with a profound remodeling of membrane receptors and alterations in cAMP dependent regulation of Ca2^+^ handling. PDE4 is expressed in human atrial myocytes and accounts for approximately 15% of PDE (phosphodiesterase) activity ([@B20]). PDE4D encoded protein has 3',5'-cyclic-AMP phosphodiesterase activity and degrades cAMP, which acts as a signal transduction molecule in multiple cell types and represents the major PDE4 subtype ([@B3]). The activity of PDEs decreased with age, and the relative PDED4 activity was lower in patients with permanent atrial fibrillation than in age-matched sinus rhythm controls ([@B19]). Previous study provided evidence that patients with pAF were found to have a decreased PDE4 activity as compared with patients in sinus rhythm ([@B34]).

Short Stature Homeobox 2 (*SHOX2*) is a member of the homeobox family of genes in which mutations associated with early-onset and familial AF ([@B11]). *SHOX2* is considered as a key regulator of sinus node development of which deficiency could lead to bradycardia in animal models ([@B31]). Previous study demonstrated *SHOX2* was susceptible for SND and AF by screening 98 SND patients and 450 individuals with AF. In the heart development of mouse and zebrafish, they also proved *SHOX2* plays an important role, the mutation of SHOX2 could lead to severe bradycardia ([@B4]; [@B33]).

Emerin (EMD) encodes a serine-rich nuclear membrane protein which located on the cytoplasmic surface of the inner nuclear membrane and related to X-linked Emery-Dreifuss muscular dystrophy (EDMD) ([@B6]). Previous study found a nonsense mutation in EMD from two EDMD families which is associated with X-linked recessive inheritance, result in serious cardiac complication, including AF ([@B25]). Cardiologic assessment revealed slow atrial fibrillation in a recent case of a 65-year-old male patient with a hemizygous duplication of 5 bases in exon 6 of the EMD, gene on the X chromosome ([@B13]; [@B36]; [@B5]).
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